Credit Suisse Ag Orchard Therapeutics PLC Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$11.88 - $16.72 $421,740 - $593,560
-35,500 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$13.2 - $20.63 $468,600 - $732,365
35,500 New
35,500 $497,000
Q1 2019

May 14, 2019
SELL
$12.01 - $19.49 $136,337 - $221,250
-11,352 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$12.4 - $18.7 $140,764 - $212,282
11,352 New
11,352 $179,000

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email